The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)
Titel:
The gefitinib long-term responder (LTR)—A cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP)
Auteur:
Gottschling, Sandra Herpel, Esther Eberhardt, Wilfried E.E. Heigener, David F. Fischer, Jürgen R. Köhne, Claus-Henning Kortsik, Cornelius Kuhnt, Thomas Muley, Thomas Meister, Michael Bischoff, Helge G. Klein, Peter Moldenhauer, Ines Schnabel, Philipp A. Thomas, Michael Penzel, Roland